Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.

Verhagen, Nathaniel B; Koerber, Nicolas K; Szabo, Aniko; Taylor, Bradley; Wainaina, J Njeri; Evans, Douglas B; Kothari, Anai N

Verhagen, Nathaniel B; Koerber, Nicolas K; Szabo, Aniko; Taylor, Bradley; Wainaina, J Njeri; Evans, Douglas B; Kothari, Anai N.

Verhagen NB; Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 8701, USA.
Koerber NK; Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 8701, USA.
Szabo A; Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Taylor B; Clinical and Translational Science Institute of Southeastern Wisconsin, Froedtert and Medical College of Wisconsin Health Network, Milwaukee, WI, USA.
Wainaina JN; Division of Infectious Disease, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Evans DB; Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 8701, USA.
Kothari AN; Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 8701, USA. akothari@mcw.edu.

Ann Surg Oncol ; 30(3): 1305-1308, 2023 03.

Article in English | MEDLINE | ID: covidwho-2154194

Subject(s)

COVID-19; Neoplasms; Humans; SARS-CoV-2; COVID-19/prevention & control; Neoplasms/surgery; Patients; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Ann Surg Oncol Journal subject: Neoplasms Year: 2023 Document Type: Article Affiliation country: S10434-022-12916-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google